Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objective of this study is to make BAY 43-9006 available for patients with advanced RCC, who failed prior systemic therapy for advanced disease (i. e., require second line treatment), and who do not have access to or are not eligible for other clinical trials with BAY 43-9006.
Critère d'inclusion
- ADVANCED RENAL CELL CARCINOMA